~~<i id='7DF0EAAEF8'><strike id='7DF0EAAEF8'><tt id='7DF0EAAEF8'><pre id='7DF0EAAEF8'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

focus

author：Wikipedia 2025-09-28 01:35:15 - browse：92915

A European regulatory panel has recommended against approval of a lung cancer drug made by Mirati Therapeutics, the company said Friday.

Mirati said it will appeal the negative opinion of the drug, called Krazati, issued by a committee of the European Medicines Agency that met this week. But for now, the adverse decision is likely to be adopted by European regulators and prevent the company from marketing the pill in Europe.

Krazati works by blocking a specific type of KRAS alteration called G12C, found in approximately 13% of lung tumors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： US judge blocks portions of new Florida elections law

entertainment

leisure time

Wikipedia

explore

hotspot

AdobeImaginethisscene:Youareacancerpatientalreadynavigatingfearanduncertaintyaroundyourtreatment,whe

WSS

Russians and Belarusians back at Wimbledon as war in Ukraine continues

FDA endorses new sterilization method for medical devices

There's an unseen cost to disruptive road

Dana Farber says 6 studies to be retracted and 31 corrected

Ukraine holds disaster drills amid fears Russia could sabotage nuclear power plant

4 dead, 2 in stable condition in Philadelphia shooting: Police

hotspot

focus

entertainment

DIEP, the 'gold standard' of breast reconstruction, is under threat

PlayStation controller and acoustic messaging: How the missing Titanic tourist sub works

Anesthesiologist group: stop taking Ozempic before surgery

Greece's new parliament sworn in following conservative party's election victory

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Trump demands the U.S. pay no more for drugs than other countries … again

Medicare bonuses could stop drug shortages under Senate plan

In Memoriam: Notable people who died in 2023

Microsoft launches AI tool for clinical documentation through Epic

leisure time

10 states plan to sue EPA over standards for residential wood

Inaction leaves children at risk from dangerous chemotherapy drug

Pumping milk in bathrooms at health conferences is common

Churchill Downs extends trainer Bob Baffert's ban through 2024

Dana Farber says 6 studies to be retracted and 31 corrected

Microsoft launches AI tool for clinical documentation through Epic

Wikipedia

explore

hotspot

hotspot